Kiyotaka Nagahama1, Hiroshi Matsushita, Mitsuru Hara
1Department of Pathology, Yokohama City University School of Medicine, Kanagawa, Japan. nag_k@med.yokohama-cu.ac.jp
Bucillamine (BCL) treatment in rheumatoid arthritis (RA) patients can cause membranous glomerulonephritis (MGN). This study reveals distinct immunoglobulin deposition patterns in BCL-induced MGN, suggesting a different pathogenesis than idiopathic MGN.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: